Dr Christina H Rens, DDS | |
202 Birch St, Abbotsford, WI 54405-9439 | |
(715) 223-4844 | |
Not Available |
Full Name | Dr Christina H Rens |
---|---|
Gender | Female |
Speciality | Dentist |
Location | 202 Birch St, Abbotsford, Wisconsin |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740235514 | NPI | - | NPPES |
33742700 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | WI4940 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Christina H Rens, DDS 202 Birch St, Po Box 147, Abbotsford, WI 54405-9439 Ph: (715) 223-4844 | Dr Christina H Rens, DDS 202 Birch St, Abbotsford, WI 54405-9439 Ph: (715) 223-4844 |
News Archive
The Salt Manufacturers Association has lodged a complaint with the Advertising Standards Authority over the use of a cartoon slug to front a new £4 million salt restriction campaign.
Scientists from the Universit- de Montr-al and its affiliated engineering school, -cole Polytechnique, have received major funding from the National Sciences and Engineering Research Council of Canada. Over $3 million was awarded to enable both institutions to launch training and mentorship programs for promising young researchers.
Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that Spectranetics Corporation, a developer, manufacturer, marketer and distributer of single-use medical devices used in minimally invasive procedures within the cardiovascular system, has selected Clinipace to manage all aspects of a pivotal cardiovascular device clinical study that will serve as the basis for 510(k) notice submission.
Access Pharmaceuticals, Inc., announced today that it has entered into a pre-licensing feasibility agreement with a leading biotechnology company to develop an oral formulation of its currently-marketed, proprietary injectable drugs. Access will utilize its proprietary Cobalamin Oral Drug Delivery Technology to develop oral formulations of the drug for pre-clinical testing.
Legislators who couldn't agree this year on how to overhaul North Carolina's Medicaid program plan to spend more time talking about the issue before the General Assembly reconvenes early next year. A legislative oversight panel subcommittee charged with examining Medicaid reform and reorganization scheduled its first meeting Wednesday. Another oversight panel also examining Medicaid governance held its first meeting this month. The House and Senate approved differing versions of legislation to change how Medicaid pays for medical expenses by shifting risk from the state to either medical provider networks or private managed-care companies (9/24).
› Verified 1 days ago
Dr. Troy D Rens, DDS Dentist Medicare: Medicare Enrolled Practice Location: 202 Birch St, Abbotsford, WI 54405 Phone: 715-223-4844 |